A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.
about
Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisitaNeutrophil elastase cleaves the murine hemidesmosomal protein BP180/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoidThree novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relation to biological and clinical phenotypes of junctional epidermolysis bullosaDemonstration of the molecular shape of BP180, a 180-kDa bullous pemphigoid antigen and its potential for trimer formationTwo forms of collagen XVII in keratinocytes. A full-length transmembrane protein and a soluble ectodomainFibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved amino acid sequencesImmunopathology and molecular diagnosis of autoimmune bullous diseasesPrevalence of pemphigus and pemphigoid autoantibodies in the general populationBullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule.Serum anti-BPAG1 auto-antibody is a novel marker for human melanomaBlockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigenEosinophils in Autoimmune Diseases.Autoimmune blistering diseases in females: a review.Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.Synergy between a plasminogen cascade and MMP-9 in autoimmune diseaseThe flavonoid luteolin inhibits Fcγ-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice.The role of complement in experimental bullous pemphigoid.The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitmentDevelopment of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosusMinocycline as a therapeutic option in bullous pemphigoid.Pathogenicity of autoantibodies in anti-p200 pemphigoid.Bullous pemphigoid: end of the century overview.Clinical spectrum, pathogenesis and treatment of linear IgA bullous dermatosis.Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid.Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid.Early neoplastic progression is complement independent.Treatment of bullous pemphigoid.Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoidThe shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases.Usefulness of Enzyme-linked Immunosorbent Assay Using Recombinant BP180 and BP230 for Serodiagnosis and Monitoring Disease Activity of Bullous PemphigoidFunctional characterization of an IgE-class monoclonal antibody specific for the bullous pemphigoid autoantigen, BP180.Therapy of autoimmune bullous diseasesCollagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha 6 integrinThe role of T cells in cutaneous autoimmune disease.Autoantibodies against adhesion molecules and structures in blistering skin diseasesBeta2-microglobulin-deficient mice are resistant to bullous pemphigoid.Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis
P2860
Q24250186-3963D124-0134-4B9A-AE92-E083414BE88FQ24339467-06E365F7-D3BC-41EC-AD7F-8A77ABBF9E9EQ24676917-8B5D1BEF-E34B-44F9-9482-40255F41E4C9Q28281786-748D83E3-F59F-45D4-A2B0-59040E37B5A8Q28283395-F33BF062-06A2-4DD4-AB75-D656D15777BFQ28302021-ED557B08-E861-4570-A4BD-D04D5E06475FQ28303627-7BD63639-90AC-47BD-BD5C-400AE934C1D2Q28647292-EA50A19E-DA61-4724-9033-16E54F3C9695Q30706183-E8CB9033-013B-4961-9D42-AA9FFCB5BB50Q30982790-B1C75375-E10D-45F4-9CDA-53C8C93ED0E3Q33521430-62FA5C36-C9ED-431A-9561-7EF22E946DC5Q33607031-1E299452-AEF2-4E8A-9793-03AA63E78877Q33640302-DC697F43-D1EA-4B00-8C43-944A9AF4E3A7Q33726907-83D49891-A73F-477F-82A0-93503EED10E0Q33726930-EFC3F786-A5A6-40D3-9B3C-C9B3B455A4B2Q34157289-2EF55638-F1EB-4034-83CF-FD358F2BA6CDQ34206776-7DFD946C-D64B-48EB-A6A5-94EAC73795F6Q34230548-59919515-B147-41E8-963A-398733852608Q34327999-FF0DD509-B9C1-4072-8422-D3FE22AC1668Q34328075-C6C9518A-66AF-482F-95B6-858AED879E0AQ34388189-D2436B5C-50C3-4678-B1B0-598C44C77918Q34480487-660DDC5C-7293-4C87-9446-492D13D8AD61Q34480493-74AB5626-791C-4E94-8412-CDE24D00F331Q34490367-80411EAA-2B09-4973-9843-0023287F708AQ34583089-791063FE-75C9-43D0-9CF4-13F40B457924Q34634415-9B75915D-7B4D-4D35-AF9A-A42C8FF82F5EQ34868949-C1A46537-47AD-4617-B79B-89CB2DAE9EFAQ34928831-FBAF443B-6F2E-49D2-A675-7A7FCD3ECD48Q35106022-804DCA84-5900-49AF-9FEB-090E8302BF33Q35423717-10EEC6FD-97CC-4E74-A2A3-DC410AE2F8B8Q35745439-C0A6762B-FBDB-46A9-8E97-3F7AB3C330DBQ35770140-494523C7-1067-45AD-9C58-5DA6F35081A8Q35888702-187A28FA-A4F7-4F3D-A8C3-F636D9372D0AQ35919150-56FF5A25-DFF0-4763-8B3F-CC83F5ED7A4BQ36090714-9FEF854D-9EF9-4183-BC59-24577CEAC912Q36235763-45F2E028-DE02-4E30-9F4A-28197298FA48Q36277428-8AD880FA-53A8-437C-9395-8D5A24303A00Q36364297-F6710EB4-FADC-4750-A7FE-51B3A8833BCCQ36380468-40851836-86D3-4210-BDFF-EEF0B6F9AD4EQ36380818-A0C4E99A-7626-4588-AA4D-1653589A732A
P2860
A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.
description
1993 nî lūn-bûn
@nan
1993 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
A passive transfer model of th ...... hemidesmosomal antigen, BP180.
@ast
A passive transfer model of th ...... hemidesmosomal antigen, BP180.
@en
type
label
A passive transfer model of th ...... hemidesmosomal antigen, BP180.
@ast
A passive transfer model of th ...... hemidesmosomal antigen, BP180.
@en
prefLabel
A passive transfer model of th ...... hemidesmosomal antigen, BP180.
@ast
A passive transfer model of th ...... hemidesmosomal antigen, BP180.
@en
P2093
P2860
P356
P1476
A passive transfer model of th ...... hemidesmosomal antigen, BP180.
@en
P2093
A F Taylor
G J Giudice
J A Fairley
P2860
P304
P356
10.1172/JCI116856
P407
P577
1993-11-01T00:00:00Z